Drink and Drugs News DDN March 2020 | Page 16

HARM REDUCTION A CRUCIAL CO Change Grow Live’s National Naloxone Conversation event was a vital opportunity to keep up the momentum for widening access, says Pete Furlong 16 • DRINK AND DRUGS NEWS • MARCH 2020 O ur sector is very aware of the crucial need to increase naloxone access and availability nationally. Last year’s ONS figures on drug-related deaths showed 4,359 fatalities related to drug poisoning in England and Wales, the highest number and annual increase – at 16 per cent – since the data set began in 1993 (DDN, September 2019, page 4). More than 2,200 had an opiate specifically implicated. To address this need, Change Grow Live hosted a National Naloxone Conversation event in Manchester in January, bringing together professionals, activists, and naloxone peer educators to collaborate on new thinking and solutions to widen the availability of naloxone across the UK. Attendees also included Change Grow Live staff and clinicians, service user reps, Addaction (now We Are With You) clinical representatives and Red Rose Recovery staff, and all contributed to wide and varied discussions and planning for further development of naloxone interventions. As harm reduction lead for Change Grow Live’s North West region, it fell to myself and Zac McMaster – head of services for Change Grow Live Mersey and Cheshire region – to welcome more than 35 delegates from across the country. To set the scene, I outlined the journey our sector has been on over the last decade regarding take-home naloxone (THN). Many of us have had to address the concerns of those who feared that the supply of THN would increase risk-taking behaviours among opiate users, but today we’re able to point to a continually increasing global evidence base that naloxone saves lives. This, coupled with the need to urgently address the growing number of drug- related deaths, means that THN is now a core component of most new tender specifications and the majority of commissioners welcome more innovation in widening the availability of naloxone for those most at risk of opiate overdose. We heard from Kirsten Horsburgh from the Scottish Drug Forum (SDF) about how Glasgow’s peer supply programme, originally Many of us have had to address the concerns of those who feared that the supply of THN would increase risk- taking behaviours among opiate users, but today we’re able to point to a continually increasing global evidence base that naloxone saves lives. WWW.DRINKANDDRUGSNEWS.COM